Hematology

Antiplatelet treatment in patients with ET or PV

Are there any patients with essential thrombocythemia (ET) or polycythemia vera (PV) who do not need antiplatelet treatment?

2020-11-10

Management of patients with secondary polycythemia

How to manage patients with secondary polycythemia? Should we perform phlebotomies or administer antiplatelet treatment?

2020-11-10

First-line cytoreductive treatment in MNPs

Which cytoreductive drug is your first-line option for the treatment of myeloproliferative neoplasms (MNPs)?

2020-11-10

Tests to establish the cause of secondary polycythemia

What tests are useful in establishing the cause of secondary polycythemia?

2020-11-10

Antiplatelet treatment in patients with thrombosis and MPNs

What antithrombotic treatment should be used in a patient with thrombosis and myeloproliferative neoplasms (MPNs)? Should antiplatelet treatment be continued?

2020-11-10

Management of patients with a low burden of <i>JAK2</i> mutation and a history of thrombosis

Management of patients with a low burden of JAK2 mutation and a history of thrombosis

What is your approach in a patient with a low burden of JAK2 mutation without other diagnostic criteria for myeloproliferative neoplasms (MPNs)? Does this approach change if the patient has a history of thrombosis?

2020-11-10